In vitro effect of amantadine and interferon α-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients
- 31 May 1999
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 42 (1) , 59-70
- https://doi.org/10.1016/s0166-3542(99)00017-0
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Risks and Benefits of Interferon-α in the Treatment of HepatitisDrug Safety, 1995
- Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-αDigestive Diseases and Sciences, 1994
- The entry of Junin virus into Vero cellsArchiv für die gesamte Virusforschung, 1994
- Infection of peripheral mononuclear blood cells by hepatitis C virusJournal of Hepatology, 1992
- Prophylaxis and Treatment of InfluenzaNew England Journal of Medicine, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Clinical Pharmacokinetics of Amantadine HydrochlorideClinical Pharmacokinetics, 1988
- Fusion mutants of the influenza virus hemagglutinin glycoproteinCell, 1985
- In vitro inhibition of rubella virus by 1-adamantanamine hydrochlorideArchiv für die gesamte Virusforschung, 1965